15 Approximately 30% of patients with neoplastic processes will develop symptomatic spinal metastasis.
ological fractures in cancer patients and due to osteoporosis. For example, 84% of patients reported marked or complete relief of preoperative pain after a kyphoplasty. 5 In addition, kyphoplasty may reduce analgesic use, further helping to improve the quality of life of cancer patients. 1 Complications of this procedure are relatively rare, 5 with extravasation of cement, cord compression, and neurological deficits being the most serious complications. 12 Fractures at adjacent segments have also been extensively reported, especially in patients with osteoporosis. In our practice, we commonly use kyphoplasty as a palliative modality to treat pathological compression fractures in cancer patients. The method is minimally invasive and causes little or no interruption of cancer therapy.
We observed delayed retropulsion of cement after kyphoplasty, indicating delayed failure of kyphoplasty-treated fractures, and these failures necessitated surgery. Given that kyphoplasty is a palliative approach in metastatic cancer patients, great care must be taken to ensure no further morbidity is created. Being able to determine predictors of kyphoplasty failure will help stratify the risk of this procedure for cancer patients. We set out to determine the incidence of this delayed structural failure in our patients to identify its risk factors. To the best of our knowledge, this is the first report examining delayed kyphoplasty failures in cancer patients.
methods data collection and Spine assessment
We retrospectively reviewed the records of all metastatic cancer patients treated at our institution from 2010 to 2013. Kyphoplasty was performed during 45 surgeries in 75 spinal levels in 37 patients. All procedures were performed using the Kyphon Kyphoplasty kit (Medtronic). Multivariate statistical analysis was performed with Microsoft Excel and SPSS software. All procedures were carried out by the Wayne State University Department of Neurosurgery staff, specifically, by Drs. Szerlip and Eltahawy. Survival data were obtained using the Social Security Death Index or last documented encounter entered into the electronic medical record of a patient. Kyphoplasty failure was defined as delayed retropulsion of cement into the spinal canal requiring operative spinal decompression and fusion.
We also included the Spinal Instability Neoplastic Score (SINS) in our analysis to design a screening procedure that identifies patients at risk for kyphoplasty failure. The SINS is used to categorize the degree of spinal instability in patients. Its scoring includes location of the metastatic tumor, presence of pain, the type of bone lesion, spinal alignment, the degree of collapse of the vertebral body, and involvement of posterolateral elements in the tumor. A spine with a SINS of 0-6 was defined as stable, of 7-12 as potentially unstable, and of 13-18 as unstable. 4 Multiple reviewers assessed cortical breaches by examining the sagittal reconstructions on preoperative CT scans and graded the breaches on a scale of 0-4, depending on the number of cortical walls that had a break. Cement extravasation was assessed by reviewing intraoperative fluoroscopy data. Data are reported as mean ± SD.
procedure
We used a standard transpedicular approach when possible and Jamshidi needles and bone fillers under anteroposterior and lateral fluoroscopy views with shots taken at 0.5-ml acrylate incremental injections.
results
Kyphoplasty procedures at 75 spinal levels were performed during 45 surgeries in 37 patients, 61% of whom were female. Of these procedures, 55% were performed in the thoracic spine and 45% in the lumbar spine. More than 50% of the metastatic tumors had originated from multiple myelomas and lung carcinomas (Table 1 ). In 4 patients (corresponding to 5.3% of all kyphoplasty procedures), delayed kyphoplasty failure met our criterion of structural failure requiring operative decompression and stabilization. Such failures occurred on average 2.88 ± 1.24 months after the kyphoplasty. The mean age was 52 years for the patients in whom kyphoplasty failed and 60 years for patients in whom kyphoplasty did not fail (Table  1) . No significant differences in age, sex, tumor type (the 4 kyphoplasty failures affected patients with neck adenocarcinoma or with cancer of the breast, lung, or colon), cement volume (mean 3.6 ml), or level (2 thoracic-level failures at T-5 and T-6, and 2 lumbar-level failures at L-1) were observed.
Overall, 80% of the patients reported improvement of their pain postoperatively (Table 2) . Among the patients in the kyphoplasty-failure group, 50% had a fractured anterior vertebral body wall, and 75% had a fractured posterior vertebral body wall; the corresponding rates were 20% and 60%, respectively, in the patients in the nonfailure group. All patients in whom kyphoplasty failed had 3 or more vertebral wall fractures, while this fracture extent was observed in 46% of those in whom kyphoplasty did not fail (p < 0.05, Fisher's exact test) ( Table 2) . One patient in the kyphoplasty-failure group had a preexisting kyphotic deformity. The odds of having kyphoplasty failure was 24.2 times greater in patients with 3 or more wall fractures than in those without these failures (95% CI 1.25-471.2, p = 0.035). Height loss of the vertebral body was 16% in the kyphoplasty-failure group and 32% in the nonfailure group (Table 2) . Interestingly, we observed minimal cement extravasation during the procedure in 1 (25.0%) of the levels in which kyphoplasty failed, and in 9 (12.7%) of the levels in the nonfailure group, with only 1 patient having posterior extravasation. Among the patients in whom kyphoplasty failed, 50% had bilateral involvement of metastatic posterolateral elements, which was observed in only 12% of patients in the nonfailure group. Mean SINSs were 10.8 for the kyphoplasty-failure group and 10.1 for the nonfailure group (p > 0.05) According to the SINS classification, the kyphoplasty-failure group included 3 patients (75%) in whom the spine was classified as potentially unstable, and the spine in (25%) 1 patient was classified as unstable. A roughly similar distribution of spinal instability was seen in the nonfailure group. The mean length of survival was 6.3 ± 2.1 months for the patients in the kyphoplasty-failure group and 17.7 ± 1.8 months for the patients in the nonfailure group (Table 1) . Among the patients in whom kyphoplasty had failed, 1 (25%) was alive at the last follow-up 18 months after the kyphoplasty, compared with 26 (63%) of the patients in the nonfailure group. Figure 1 shows pre-and intraoperative spinal images, and representative images after kyphoplasty failure in the 4 patients in whom kyphoplasty failed. Preoperatively, 2 of the 4 patients had large lucent areas within the vertebral body, with a very thin cortical bone. All 4 patients in the kyphoplasty-failure group initially presented with recurrence of preoperative pain that had resolved after the first procedure. One patient also had weakness in the lower extremity.
discussion
Our results indicate that kyphoplasty-failure rates in metastatic disease are much higher than previously reported in similar studies of patients with metastatic cancer 5 or osteoporosis. 16 The failure rate observed probably resulted from a combination of local disease progression and catastrophic structural failure of the vertebral body due to structural instability. We did not find previously published reports on delayed kyphoplasty failure. Many studies have reported spinal cord compression at the time of the procedure resulting from dorsal cement extravasation. One recent study of 97 kyphoplasty procedures for metastatic disease reported that none of the patients required a return to the operating room for cord compression due to cement dislodgement and noted a cement extravasation rate of 9%. 5 One large meta-analysis including both osteoporotic and metastatic lesions found a cement extravasation rate of 8.6% (193 out of 2239 cases) and a spinal cord compression rate of 0.2% (1 out of 431 cases).
14 Moreover, a systematic review identified 8 case reports out of 168 reviewed studies reporting posterior cement extravasation requiring operative decompression. 3 Only 1 of these 8 reports mentioned that spinal cord compression was initially performed to address metastatic cancer. In this report, a 50-year-old woman with a T-1 pathological compression fracture from metastatic breast cancer had intraoperative cement extravasation and developed weakness over a 48-hour postoperative period. She was taken back to the operating room for a decompression. 12 This observation is in contrast to those in our study in which kyphoplasty failure was delayed on average by 2-3 months. In fact, none of the patients with delayed kyphoplasty failure in our series had any posterior extravasation of cement as monitored with intraoperative fluoroscopy, and none needed to return to the operating room immediately after the procedure.
Currently, kyphoplasty is being combined with other modalities, including radiotherapy to the kyphoplasty level, and these combined approaches resolve pain well; 8 however, these approaches require monitoring for any possible effects on delayed kyphoplasty failure. Radiated vertebral bodies have been shown to have a higher rate of fracture progression, especially if the lesion is large and lytic. 13 Among the 4 patients in our study in whom kyphoplasty failed, 2 (50%) received radiation before kyphoplasty. One patient (25%) in the kyphoplasty-failure group had preoperative chemotherapy. By comparison, in the nonfailure group, 5 (12.2%) of the patients underwent radiotherapy before kyphoplasty, and 24 (58.5%) underwent chemotherapy. Adjuvant radiation was recommended for any biopsies taken during the kyphoplasty procedure that indicated the presence of cancer cells. Salvage surgery consisted of posterolateral decompression and spinal fusion at the lumbar levels and minimally invasive surgery with a lateral extracavitary approach and fusion at the thoracic levels. All patients experienced improvement in their predecompression symptoms.
Predictors of kyphoplasty failure in our study included overall health of the vertebral body as measured by the integrity of the cortical walls. In addition, the SINS indicated that junctional levels may be more susceptible to failure; for example, 50% of the kyphoplasty failures in this study occurred at junctional levels (that is, at L-1). This finding was likely related to the increased mobility at these levels. Lastly, posterolateral element involvement in the metastasis was more frequent in the kyphoplasty-failure group. Posterolateral involvement because of the lack of a competent posterior tension band was likely responsible for decreased overall spinal stability with resultant increased load on the vertebral body.
Previous studies have reported cement extravasation as a risk factor for kyphoplasty failure; however, we noted only minimal cement extravasation in 1 of the cases in which kyphoplasty eventually failed. A large series of 190 cases of kyphoplasty performed in myeloma patients reported a cement extravasation rate of 5%, with 1 patient requiring operative decompression. 10 This study reported a posterior defect in the vertebral body that had been missed because only a preoperative MRI scan was obtained, prompting the authors to recommend routine preoperative CT scanning for metastatic fractures. 10 Lastly, a study of 99 cases of kyphoplasty in metastatic cancer patients reported a 12% cement extravasation rate, with no delayed failures over a 2-year follow-up period. 11 This study, however, excluded patients with tumor involvement of the posterior cortex and spinal stenosis.
In our study, the patients in whom the kyphoplasty failed were younger and had shorter postoperative survival. Although we did not identify a causal relationship, this observation reinforces the idea that the lower survival could have resulted from a combination of disease progression with structural kyphoplasty failure. Our study sample was small, however, precluding any solid conclusions.
conclusions
To the best of our knowledge, we report the first study of delayed kyphoplasty failure. We noted that 5% of kyphoplasty procedures in patients with spinal metastases showed delayed failure, which necessitated operative decompression. In addition, our report identified multiple possible predictors of delayed kyphoplasty failures. The most important risk factor appeared to be the overall integrity of the vertebral body. Others included the junctional levels, involvement of the posterolateral element in the disease, and previous radiotherapy. According to our experience, it appears that along with the trend toward minimizing extensive surgical interventions in metastatic disease of the vertebral column, we now offer kyphoplasty as treatment more liberally, occasionally approaching the limits of its indications. On the basis of these findings, we recommend caution when performing a kyphoplasty at junctional levels with multiple cortical defects. While additional randomized trials are necessary, we hope this study will aid in identifying patients at high risk for kyphoplasty failure and will help surgeons make informed decisions about which surgical intervention will provide the best risk-to-benefit ratio. 
